Literature DB >> 7681711

GM-CSF and G-CSF in Felty's syndrome.

D R Wagner1, C Combe, U Gresser.   

Abstract

The risk of infection is increased in patients with Felty's syndrome, neutropenia being one of the main reasons for the susceptibility to infection. We report the case of a 56-year-old patient with Felty's syndrome in whom successive therapy with GM-CSF, splenectomy, and G-CSF was tried because of recurrent severe infections. Therapy with GM-CSF and G-CSF resulted in improvement of neutropenia and in successful treatment of cutaneous and pulmonary infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681711     DOI: 10.1007/bf00180001

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  28 in total

1.  Resolution of Felty's syndrome with cyclophosphamide.

Authors:  P R Neish; H A Fuchs
Journal:  J Rheumatol       Date:  1989-05       Impact factor: 4.666

2.  Leukokinetic studies. XIV. Blood neutrophil kinetics in chronic, steady-state neutropenia.

Authors:  C R Bishop; G Rothstein; H E Ashenbrucker; J W Athens
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

3.  High-dose immunoglobulin in Felty's syndrome.

Authors:  M Ahern; J Harkness; P Maddison; S Forskitt
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

4.  Clonal analysis of progenitor cell commitment of granulocyte or macrophage production.

Authors:  D Metcalf; A W Burgess
Journal:  J Cell Physiol       Date:  1982-06       Impact factor: 6.384

5.  Plasmapheresis in Felty's syndrome.

Authors:  B Clotet; E Argelagués; J Juncà; M Grifol; J Sanz; A Ribera; E Lience; M Foz
Journal:  Scand J Rheumatol       Date:  1985       Impact factor: 3.641

6.  GM-CSF in the treatment of Felty syndrome.

Authors:  G Joseph; D H Neustadt; J Hamm; M Kellihan; T Hadley
Journal:  Am J Hematol       Date:  1991-05       Impact factor: 10.047

7.  An inhibitor of leucocyte movement in the plasma of patients with rheumatoid arthritis.

Authors:  J R Walker; M J Smith
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

8.  Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome.

Authors:  N I Abdou
Journal:  Arthritis Rheum       Date:  1983-08

9.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.

Authors:  J E Groopman; R T Mitsuyasu; M J DeLeo; D H Oette; D W Golde
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

10.  Felty syndrome: autoimmune neutropenia or immune-complex-mediated disease?

Authors:  F C Breedveld; G J Lafeber; G Doekes; F H Claas; A Cats
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

View more
  2 in total

1.  The Diagnosis Felt(y) Right: A Case Report of Felty Syndrome With Limited Articular Involvement.

Authors:  Victor E Serrano Santiago; Zack Morgan
Journal:  Cureus       Date:  2022-04-29

Review 2.  Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.

Authors:  J E Frampton; C R Lee; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.